Histogen Inc. announced that Steven J. Mento, Ph.D., a current member of the Histogen Board of Directors, has been appointed Executive Chairman and Interim President, effective November 8, 2021. David Crean, Ph.D., a current member and the Chairman of the Histogen Board of Directors, will continue to serve as a member of the Board of Directors and as the newly appointed Lead Independent Director. Richard Pascoe has stepped down as President and as a member of the company?s Board of Directors, effective November 8, 2021, to pursue different opportunities. A search has commenced to identify a permanent CEO.